460 related articles for article (PubMed ID: 9890667)
21. Immunologic markers in non-Hodgkin's lymphoma.
Freedman AS; Nadler LM
Hematol Oncol Clin North Am; 1991 Oct; 5(5):871-89. PubMed ID: 1938759
[TBL] [Abstract][Full Text] [Related]
22. B cell hyperactivity is a function of T cell derived cytokines in systemic lupus erythematosus.
al-Janadi M; Raziuddin S
J Rheumatol; 1993 Nov; 20(11):1885-91. PubMed ID: 7508509
[TBL] [Abstract][Full Text] [Related]
23. The immunophenotype of blast transformation of chronic myelogenous leukemia: a high frequency of mixed lineage phenotype in "lymphoid" blasts and A comparison of morphologic, immunophenotypic, and molecular findings.
Khalidi HS; Brynes RK; Medeiros LJ; Chang KL; Slovak ML; Snyder DS; Arber DA
Mod Pathol; 1998 Dec; 11(12):1211-21. PubMed ID: 9872654
[TBL] [Abstract][Full Text] [Related]
24. Low level CD20 expression on T cell malignancies.
Warzynski MJ; Graham DM; Axtell RA; Zakem MH; Rotman RK
Cytometry; 1994 Jun; 18(2):88-92. PubMed ID: 7523045
[TBL] [Abstract][Full Text] [Related]
25. In vitro intrathymic differentiation kinetics of human fetal liver CD34+CD38- progenitors reveals a phenotypically defined dendritic/T-NK precursor split.
Plum J; De Smedt M; Verhasselt B; Offner F; Kerre T; Vanhecke D; Leclercq G; Vandekerckhove B
J Immunol; 1999 Jan; 162(1):60-8. PubMed ID: 9886370
[TBL] [Abstract][Full Text] [Related]
26. Flow cytometry of peripheral blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells, lymphocyte subsets and detection of minimal residual disease after treatment.
Babuŝíková O; Tomová A; Kusenda J; Gyárfás J
Neoplasma; 2001; 48(5):350-7. PubMed ID: 11845978
[TBL] [Abstract][Full Text] [Related]
27. A comparison of some leucocyte differentiation markers and the adenosine deaminase and purine nucleoside phosphorylase values in B and T cell leukemias and lymphomas.
Mesárosová A; Hrivnáková A; Babusíková O
Neoplasma; 1995; 42(6):307-12. PubMed ID: 8592572
[TBL] [Abstract][Full Text] [Related]
28. Biological and clinical features of B-precursor childhood acute lymphoblastic leukemia showing CD2 and/or E-rosette co-expression.
Cantù-Rajnoldi A; Putti MC; Schirò R; Biondi A; Cattoretti G; Valeggio C; Castagni M; Basso G
Haematologica; 1992; 77(5):384-91. PubMed ID: 1362385
[TBL] [Abstract][Full Text] [Related]
29. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
[TBL] [Abstract][Full Text] [Related]
30. [Phenotypic changes in refractory and relapse acute lymphoblastic leukemias].
Gómez E; San Miguel JF; González M; Orfao A; Cañizo MC; Ciudad J; López Borrasca A
Sangre (Barc); 1991 Jun; 36(3):201-4. PubMed ID: 1948539
[TBL] [Abstract][Full Text] [Related]
31. Laboratory, morphologic, and immunophenotypic correlates of surface immunoglobulin heavy chain isotype expression in B-cell chronic lymphocytic leukemia.
Shen PU; Fuller SG; Rezuke WN; Sherburne BJ; DiGiuseppe JA
Am J Clin Pathol; 2001 Dec; 116(6):905-12. PubMed ID: 11764081
[TBL] [Abstract][Full Text] [Related]
32. Leukemia-associated phenotypes: their characteristics and incidence in acute leukemia.
Babusíková O; Glasová M; Koníková E; Kusenda J
Neoplasma; 1996; 43(6):367-72. PubMed ID: 8996560
[TBL] [Abstract][Full Text] [Related]
33. Coordinated regulation in human T cells of nucleotide-hydrolyzing ecto-enzymatic activities, including CD38 and PC-1. Possible role in the recycling of nicotinamide adenine dinucleotide metabolites.
Deterre P; Gelman L; Gary-Gouy H; Arrieumerlou C; Berthelier V; Tixier JM; Ktorza S; Goding J; Schmitt C; Bismuth G
J Immunol; 1996 Aug; 157(4):1381-8. PubMed ID: 8759717
[TBL] [Abstract][Full Text] [Related]
34. Differential expression of cell surface antigens on subsets of CD4+ and CD8+ T cells.
Olson DP; Dombkowski DM; Kelliher AS; Pontillo C; Anderson DC; Preffer FI
Med Sci Monit; 2004 Sep; 10(9):BR339-45. PubMed ID: 15328479
[TBL] [Abstract][Full Text] [Related]
35. Modulation of surface transferrin receptors in lymphoid cells de novo infected with human immunodeficiency virus type-1.
Savarino A; Calosso L; Piragino A; Martini C; Gennero L; Pescarmona GP; Pugliese A
Cell Biochem Funct; 1999 Mar; 17(1):47-55. PubMed ID: 10191508
[TBL] [Abstract][Full Text] [Related]
36. Human acute myeloid leukemia CD34+/CD38- progenitor cells have decreased sensitivity to chemotherapy and Fas-induced apoptosis, reduced immunogenicity, and impaired dendritic cell transformation capacities.
Costello RT; Mallet F; Gaugler B; Sainty D; Arnoulet C; Gastaut JA; Olive D
Cancer Res; 2000 Aug; 60(16):4403-11. PubMed ID: 10969785
[TBL] [Abstract][Full Text] [Related]
37. Definition of acute biphenotypic leukemia.
Matutes E; Morilla R; Farahat N; Carbonell F; Swansbury J; Dyer M; Catovsky D
Haematologica; 1997; 82(1):64-6. PubMed ID: 9107085
[TBL] [Abstract][Full Text] [Related]
38. Expression pattern of hybrid phenotype in adult acute lymphoblastic leukemia.
Nakase K; Kita K; Miwa H; Nishii K; Shiku H; Nasu K; Dohy H; Kyo T; Kamada N; Tsutani H
Cancer Detect Prev; 2001; 25(4):394-405. PubMed ID: 11531016
[TBL] [Abstract][Full Text] [Related]
39. The immunophenotype of pre-TALL/LBL revisited.
Lewis RE; Cruse JM; Sanders CM; Webb RN; Tillman BF; Beason KL; Lam J; Koehler J
Exp Mol Pathol; 2006 Oct; 81(2):162-5. PubMed ID: 16908018
[TBL] [Abstract][Full Text] [Related]
40. Expression of CD5 and CD38 by human CD5- B cells: requirement for special stimuli.
Zupo S; Dono M; Massara R; Taborelli G; Chiorazzi N; Ferrarini M
Eur J Immunol; 1994 Jun; 24(6):1426-33. PubMed ID: 7515814
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]